Search

Meeting Coverage:

American Academy of Ophthalmology

AAO: 2021

Home-Based Glaucoma Monitoring

Oluwatosin U. Smith, MD

Show Description +

Oluwatosin U. Smith, MD, discusses the options available for at-home glaucoma monitoring, how these options compare to those available in the office, and how they will improve patient care in the future.

Posted: 11/14/2021

Keywords:

Home Monitoring

Up Next

Diversity and Inclusion in Ophthalmology and Its Potential Effects on Patient Care

Diversity and Inclusion in Ophthalmology and Its Potential Effects on Patient Care

Fasika A. Woreta, MD, MPH

Change in IOP Following Standalone Phacoemulsification

Change in IOP Following Standalone Phacoemulsification

Adam Rothman, MD

Preparing for Same-Day Bilateral Cataract Surgery

Preparing for Same-Day Bilateral Cataract Surgery

Presbyopia-Correcting IOLs: Pearls and Pitfalls

Presbyopia-Correcting IOLs: Pearls and Pitfalls

William B. Trattler, MD

Saving Time With an Intracanalicular Dexamethasone Insert

Saving Time With an Intracanalicular Dexamethasone Insert

Updates on Subretinal/Suprachoroidal Gene Therapy for Wet AMD

Updates on Subretinal/Suprachoroidal Gene Therapy for Wet AMD

Robert Avery, MD

A Peek at the Latest Surgical Instruments

A Peek at the Latest Surgical Instruments

David R. Chow, MD

AI Screening Models for DR Go Head-to-Head

AI Screening Models for DR Go Head-to-Head

Aaron Y. Lee, MD

Using OCT To Predict and Track AMD Progression

Using OCT To Predict and Track AMD Progression

Srinivas R. Sadda, MD

Promising Findings with Transplanted RPE Cells for Patients with GA

Promising Findings with Transplanted RPE Cells for Patients with GA

Michael S. Ip, MD

Updates on Subretinal/Suprachoroidal Gene Therapy for Wet AMD

Updates on Subretinal/Suprachoroidal Gene Therapy for Wet AMD

Robert Avery, MD

Top-Line Results from DERBY and OAKS—the Good and the Bad

Top-Line Results from DERBY and OAKS—the Good and the Bad

Charles C. Wykoff, MD, PhD

Skip 4-Week Dosing With Brolucizumab

Skip 4-Week Dosing With Brolucizumab

Arshad M. Khanani, MD

Cataract Surgery in the Setting of Endothelial Dysfunction

Cataract Surgery in the Setting of Endothelial Dysfunction

Francis Price, MD

Premium IOL Implantation After Laser Vision Correction

Premium IOL Implantation After Laser Vision Correction

Zeba Syed, MD

IOL Scaffold for the Prevention of Cataract Surgery Complications

IOL Scaffold for the Prevention of Cataract Surgery Complications

Ashvin Agarwal, MD

Patient-Reported Outcomes With a Presbyopia Eye Drop

Patient-Reported Outcomes With a Presbyopia Eye Drop

Cathleen M. McCabe, MD

AI’s Effect on Clinical Practice

AI’s Effect on Clinical Practice

Aaron Y. Lee, MD

Pearls for Multifocal IOL Exchange

Pearls for Multifocal IOL Exchange

Marjan Farid, MD

Pearls From a Senior Ophthalmologist to a Young Ophthalmologist

Pearls From a Senior Ophthalmologist to a Young Ophthalmologist

Marguerite McDonald, MD

AI-Guided Image Recognition for Cup-to-Disc Estimation

AI-Guided Image Recognition for Cup-to-Disc Estimation

Dylan Stevens, MD

Back to All Videos

Home-Based Glaucoma Monitoring

Oluwatosin U. Smith, MD

Oluwatosin U. Smith, MD, discusses the options available for at-home glaucoma monitoring, how these options compare to those available in the office, and how they will improve patient care in the future.

Posted: 11/14/2021

Keywords:

Home Monitoring

Please log in to leave a comment.

More From AAO: 2021 Coverage

A Peek at the Latest Surgical Instruments

A Peek at the Latest Surgical Instruments

David R. Chow, MD

AI Screening Models for DR Go Head-to-Head

AI Screening Models for DR Go Head-to-Head

Aaron Y. Lee, MD

Using OCT To Predict and Track AMD Progression

Using OCT To Predict and Track AMD Progression

Srinivas R. Sadda, MD

Promising Findings with Transplanted RPE Cells for Patients with GA

Promising Findings with Transplanted RPE Cells for Patients with GA

Michael S. Ip, MD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of AAO: 2021.